Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease.
about
Central Nervous System-Peripheral Immune System Dialogue in Neurological Disorders: Possible Application of Neuroimmunology in UrologyNeuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent PerspectivesMicroglia-Mediated Neuroinflammation and Neurotrophic Factor-Induced Protection in the MPTP Mouse Model of Parkinson's Disease-Lessons from Transgenic MiceBridge between neuroimmunity and traumatic brain injuryRegulatory T cell in stroke: a new paradigm for immune regulationT cells in the central nervous system: messengers of destruction or purveyors of protection?Vaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance?Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunityProtective Microglia and Their Regulation in Parkinson's DiseaseLipopolysaccharide from Rhodobacter sphaeroides Attenuates Microglia-Mediated Inflammation and Phagocytosis and Directs Regulatory T Cell ResponsePACAP deficiency sensitizes nigrostriatal dopaminergic neurons to paraquat-induced damage and modulates central and peripheral inflammatory activation in miceRegulatory T cells in central nervous system injury: a double-edged swordPhagocytic clearance in neurodegeneration.Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease.Tuftsin-driven experimental autoimmune encephalomyelitis recovery requires neuropilin-1.Glial innate immunity generated by non-aggregated alpha-synuclein in mouse: differences between wild-type and Parkinson's disease-linked mutants.Proteomic modeling for HIV-1 infected microglia-astrocyte crosstalk.Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice.Molecular dialogs between the ischemic brain and the peripheral immune system: dualistic roles in injury and repairExaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient miceControl of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disordersFunctional proteomic analysis for regulatory T cell surveillance of the HIV-1-infected macrophage.BCG vaccine-induced neuroprotection in a mouse model of Parkinson's disease.Evidence of inflammatory system involvement in Parkinson's disease.Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseasesMicroglial dysregulation in psychiatric diseaseT-Lymphocyte Deficiency Exacerbates Behavioral Deficits in the 6-OHDA Unilateral Lesion Rat Model for Parkinson's Disease.HLA-DRB1 alleles are associated with the susceptibility to sporadic Parkinson's disease in Chinese Han populationThe endotoxin-induced neuroinflammation model of Parkinson's disease.Long leukocyte telomere length at diagnosis is a risk factor for dementia progression in idiopathic parkinsonism.Granulocyte-macrophage colony stimulating factor exerts protective and immunomodulatory effects in cortical traumaEndogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis.Tyrosine Kinase Inhibition Regulates Early Systemic Immune Changes and Modulates the Neuroimmune Response in α-SynucleinopathyDual destructive and protective roles of adaptive immunity in neurodegenerative disorders.Prospects of statins in Parkinson diseaseChaperoned amyloid proteins for immune manipulation: α-Synuclein/Hsp70 shifts immunity toward a modulatory phenotypeFractalkine over expression suppresses α-synuclein-mediated neurodegenerationMitochondrial permeability transition pore component cyclophilin D distinguishes nigrostriatal dopaminergic death paradigms in the MPTP mouse model of Parkinson's disease.The association between neovascular age-related macular degeneration and regulatory T cells in peripheral blood.Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology
P2860
Q26745684-A72F36EC-08E9-476A-98BD-8BD371A84AC1Q26747508-C9C3BF19-67F0-4B93-A997-1E711C189D5FQ26773064-C6A739F5-23F2-42FD-862C-566F5192D4A8Q26827612-2E26E2C4-9912-494F-8437-1D229B15D547Q26995751-A5C24683-2C4A-4416-AE31-114A108C026CQ27001059-90084784-A1A6-413C-88F0-6A31D1CC9C92Q27015811-DC70E6E3-99E2-425B-8986-BFF9F309A8DAQ27027973-BF24F42C-7A9B-4161-AF9F-9C509AAF701DQ28079731-D619652A-CEDE-43A3-89FA-5DCA08448E18Q28268463-118A5A93-A409-4096-ABF4-DB3F45FB6055Q28397422-ABED493A-BF39-4C70-A41F-50B8ADE68584Q30303089-37AF9995-F39D-4F92-AE04-2DF4CE82826DQ30427542-03998872-9BFA-4AF2-8128-E6670B4DDD51Q30493249-DAAEE713-E8F3-46CE-840C-E9673908394FQ30743356-DCBD2C87-334C-43F0-BD3B-1924393D54C4Q30991616-3196CABA-348D-4199-B468-A76DE5A94F09Q33346280-4F0C80AF-BF38-400E-8CB0-0DD162B189A1Q33354106-B6ECAE19-99B1-4AA3-8BA0-263916C7836EQ33583258-300D2CB4-BC68-4641-A49A-032AF6501458Q33615151-F2529285-683F-4940-951F-1D46DB0FEE91Q33670805-86DECFE5-F54E-42C0-B1A0-81BCE6C3BE5FQ33721196-2BD6A3F5-CAE7-45DF-9A3F-DB4390DCD817Q33815568-32916606-7C94-43D7-BA3C-370DEB4C0A15Q33890818-7C3C8214-6273-4B9D-9290-9EE06EF256C6Q34071942-E3C63C8E-91E0-4E78-BB11-318F453C7FABQ34345744-9008D847-973D-4765-B0AD-8725CF2C1E43Q34392867-3595ED6F-F237-4D25-9984-09A0983BC379Q34472048-FF276802-0E49-4C50-9EC7-A64CB7A8A161Q34557246-49447DF0-3B93-4E51-A663-92499A367727Q34688885-2F30DDE8-35FE-4D1B-9B18-399FC40B60B4Q34980223-4B48E80C-80E6-4E6D-9554-751347321B12Q34992177-A20EC1CC-14FF-477B-8886-D0E9F70DA93BQ35019131-1D654180-4EC0-4D94-9027-D48882899805Q35068792-275F75AB-CC97-473E-B9B5-B9761FD2AC1EQ35094028-2C894EBA-54D6-47FB-9D70-377756F7A677Q35285839-C1F22EE0-5193-4ADE-8A2D-9AC2B17EA668Q35591414-DFC100F9-B606-435B-BE21-84A38CDA746AQ35799121-C0055725-9C52-480A-B534-F4AA13A146C7Q35799403-2D4CFBA9-E3EF-40BF-BC74-298441D91345Q36018333-A356896D-BD51-4E6E-A4F8-8C7B504A1580
P2860
Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Neuroprotective activities of ...... model of Parkinson's disease.
@en
type
label
Neuroprotective activities of ...... model of Parkinson's disease.
@en
prefLabel
Neuroprotective activities of ...... model of Parkinson's disease.
@en
P2093
P356
P1476
Neuroprotective activities of ...... model of Parkinson's disease.
@en
P2093
Ashley D Reynolds
Howard E Gendelman
Jianou Liu
R Lee Mosley
Rebecca Banerjee
P304
P356
10.1189/JLB.0507296
P577
2007-08-03T00:00:00Z